Natco Pharma (India) Market Value
| NATCOPHARM | 1,337 13.80 1.02% |
| Symbol | Natco |
Natco Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Natco Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Natco Pharma.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in Natco Pharma on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Natco Pharma Limited or generate 0.0% return on investment in Natco Pharma over 30 days. Natco Pharma is related to or competes with DMCC SPECIALITY, General Insurance, Thirumalai Chemicals, Mangalore Chemicals, TECIL Chemicals, and Som Distilleries. Natco Pharma is entity of India. It is traded as Stock on NSE exchange. More
Natco Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Natco Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Natco Pharma Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.21) | |||
| Maximum Drawdown | 7.13 | |||
| Value At Risk | (2.69) | |||
| Potential Upside | 3.0 |
Natco Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Natco Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Natco Pharma's standard deviation. In reality, there are many statistical measures that can use Natco Pharma historical prices to predict the future Natco Pharma's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.48) | |||
| Treynor Ratio | (0.60) |
Natco Pharma Limited Backtested Returns
Natco Pharma Limited has Sharpe Ratio of -0.13, which conveys that the firm had a -0.13% return per unit of risk over the last 3 months. Natco Pharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Natco Pharma's Standard Deviation of 1.67, risk adjusted performance of (0.1), and Mean Deviation of 1.33 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.38, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Natco Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Natco Pharma is expected to be smaller as well. At this point, Natco Pharma Limited has a negative expected return of -0.21%. Please make sure to verify Natco Pharma's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Natco Pharma Limited performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.43 |
Average predictability
Natco Pharma Limited has average predictability. Overlapping area represents the amount of predictability between Natco Pharma time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Natco Pharma Limited price movement. The serial correlation of 0.43 indicates that just about 43.0% of current Natco Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 138.44 |
Natco Pharma Limited lagged returns against current returns
Autocorrelation, which is Natco Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Natco Pharma's stock expected returns. We can calculate the autocorrelation of Natco Pharma returns to help us make a trade decision. For example, suppose you find that Natco Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Natco Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Natco Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Natco Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Natco Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Natco Pharma Lagged Returns
When evaluating Natco Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Natco Pharma stock have on its future price. Natco Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Natco Pharma autocorrelation shows the relationship between Natco Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Natco Pharma Limited.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Natco Stock
Natco Pharma financial ratios help investors to determine whether Natco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natco with respect to the benefits of owning Natco Pharma security.